Tzuling Cheng is an accomplished professional with extensive experience in biomarker strategy and translational science within the pharmaceutical industry. Currently serving as Associate Director at Deciphera Pharmaceuticals since October 2023, Tzuling has previously held the same title at Arcus Biosciences, where responsibilities included developing biomarker strategies for clinical programs and managing cross-functional teams. Prior roles include significant positions at ZS, Bristol Myers Squibb, IDEAYA Biosciences, and Merck, focusing on targeted cancer therapies, preclinical program development, and strategy execution. Tzuling's academic background includes a Ph.D. in Cell/Cancer Biology from UT Southwestern Medical Center, complemented by degrees in Molecular Medicine and Agriculture Chemistry from National Taiwan University of Medicine and National Taiwan University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices